Canada markets closed

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
12.93-0.47 (-3.51%)
At close: 04:00PM EST
12.72 -0.21 (-1.62%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close13.40
Open13.50
Bid12.85 x 3000
Ask12.99 x 900
Day's Range12.51 - 13.90
52 Week Range7.58 - 16.23
Volume64,819
Avg. Volume30,672
Market Cap166.127M
Beta (5Y Monthly)3.05
PE Ratio (TTM)N/A
EPS (TTM)-0.70
Earnings DateMar 31, 2024 - Apr 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.00
  • GlobeNewswire

    Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

    STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on the expansion of the clinical trial into Europe. The Company's application to expand Flamingo-01 into Europe has been

  • GlobeNewswire

    Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

    STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on the Phase III clinical trial, Flamingo-01. Data Safety Monitoring Board (DSMB) The Flamingo-01 DSMB met twice in 2023 and recommended to continue the study as is

  • Simply Wall St.

    We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...